Canopy Growth (CGC) Current Assets (2017 - 2026)
Canopy Growth (CGC) posted Current Assets of $386.1 million for Q1 2026, up 309.82% sequentially from $94.2 million in Q4 2025, and up 88.07% YoY from $205.3 million in Q1 2025.
Canopy Growth (CGC) Current Assets (2017 - 2026) Analysis & Trends
Canopy Growth has reported Current Assets for 10 years, with the latest figure at $386.1 million in Q1 2026.
- Quarterly Current Assets rose 88.07% year-over-year to $386.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $386.1 million (up 88.07% YoY) and the FY2026 annual result came in at $386.1 million, up 88.07% from the prior year.
- Current Assets grew to $386.1 million in Q1 2026 per CGC's latest filing, from $94.2 million in the prior quarter.
- Over five years, Current Assets peaked at $1.4 billion in Q1 2022 and troughed at $94.2 million in Q4 2025.
- A 5-year average of $522.4 million and a median of $323.9 million in 2025 frame the typical range for Current Assets.
- The sharpest annual moves came in 2023 and 2026: Current Assets sank 68.25% in 2023, then soared 88.07% in 2026.
- Over 5 years, Current Assets stood at $846.9 million in 2022, then plunged by 65.54% to $291.8 million in 2023, then sank by 64.34% to $104.1 million in 2024, then slipped by 9.47% to $94.2 million in 2025, then soared by 309.82% to $386.1 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $386.1 million, $94.2 million, and $323.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.22 Bn |
| 10 | Canopy Growth | 435.44 Mn | 188.43 Mn | 16.08 Mn | 366.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 366.06 Mn |
| Mar 31, 2026 | 386.09 Mn |
| Dec 31, 2025 | 94.21 Mn |
| Sep 30, 2025 | 323.95 Mn |
| Jun 30, 2025 | 218.94 Mn |
| Mar 31, 2025 | 205.29 Mn |
| Dec 31, 2024 | 104.06 Mn |
| Sep 30, 2024 | 287.11 Mn |
| Jun 30, 2024 | 261.60 Mn |
| Mar 31, 2024 | 275.46 Mn |
| Dec 31, 2023 | 291.82 Mn |
| Sep 30, 2023 | 368.26 Mn |
| Jun 30, 2023 | 657.52 Mn |
| Mar 31, 2023 | 796.84 Mn |
| Dec 31, 2022 | 846.93 Mn |
| Sep 30, 2022 | 1.16 Bn |
| Jun 30, 2022 | 1.24 Bn |
| Mar 31, 2022 | 1.36 Bn |
| Dec 31, 2021 | 1.58 Bn |
| Sep 30, 2021 | 1.99 Bn |